Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
1.725
-0.315 (-15.44%)
At close: Sep 14, 2026, 4:00 PM EDT
1.770
+0.045 (2.61%)
After-hours: Sep 14, 2026, 7:59 PM EDT
CNTB Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, CNTB stock has a consensus rating of "Strong Buy" and an average price target of $7.25. The average 1-year stock price forecast is 320.29% higher than the current stock price, while the lowest is $4.00 (+131.88%) and the highest is $10 (+479.71%).
Price Target: $7.25 (+320.29%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for CNTB stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 7 | 6 | 7 | 7 |
| Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 7 | 7 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $7 | Buy | Reiterates | $7 | +305.80% | Sep 11, 2026 |
| BTIG | BTIG | Buy Maintains $10 | Buy | Maintains | $10 | +479.71% | Aug 27, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $7 | Buy | Reiterates | $7 | +305.80% | Aug 26, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $7 | Buy | Maintains | $7 | +305.80% | Aug 13, 2026 |
| Lake Street | Lake Street | Buy Maintains $9 | Buy | Maintains | $9 | +421.74% | Jul 15, 2026 |
Financial Forecast
Revenue This Year
7.32M
from 64.00K
Increased by 11,333.04%
Revenue Next Year
12.64M
from 7.32M
Increased by 72.80%
EPS This Year
-1.00
from -1.00
EPS Next Year
-0.75
from -1.00
EPS and Forward PE are based on non-GAAP adjusted numbers.